Cathie Wood Portfolio: 5 Biggest Losers

Page 5 of 5

1. Editas Medicine, Inc. (NASDAQ:EDIT)

Number of Hedge Fund Holders: 22     

Year-to-Date Decline in Share Price: 52%

Editas Medicine, Inc. (NASDAQ:EDIT) is a genome editing company. Insider selling has sent the shares sliding in the past few months. However, this freefall has stemmed somewhat in early November as the firm beat market estimates on earnings for the third quarter. 

Latest securities filings reveal that ARK Investment Management owned 6.2 million shares in Editas Medicine, Inc. (NASDAQ:EDIT) at the end of the third quarter of 2021 worth $258 million.

Among the hedge funds being tracked by Insider Monkey, Chicago-based investment firm Citadel Investment Group is a leading shareholder in Editas Medicine, Inc. (NASDAQ:EDIT) with 740,508 shares worth more than $30 million.  

You can also take a peek at 10 Best Healthcare Dividend Stocks to Buy Now and 10 Dividend Stocks with Over 20 Years of Dividend Increases.

Page 5 of 5